Beyond the Scope
The DPA is thrilled to announce the launch of Beyond The Scope, a new podcast focusing on the hot topics in digital pathology. Co-hosts Dr. Giovanni Lujan (OSUWMC) and Dr. David Tulman (Instapath) converse with the key opinion leaders in an engaging format discussing all of the new research, technology, and workflows emerging in digital pathology. Beyond The Scope aims to cover specific topics ranging from artificial intelligence to computational pathology, whole slide imaging to in/ex-vivo microscopy, regulation and commercialization, and more!
If you are interested in being a guest on Beyond The Scope, or have requests for topics the podcast should cover, please submit the request form, HERE.
Episode 9 - George Green, PhD | Bristol Myers Squibb (posted April 2021)
George Green joins Beyond the Scope to discuss the pharmaceutical industry's perspective on digital pathology and artificial intelligence. The conversation revolves around how digital pathology will see increased applications in the current era of precision medicine.
- 1:22 Introduction
- 4:15 The companion diagnostics revolution in pharma
- 9:54 Early applications of digital pathology in pharma
- 14:38 How the mindset of pathologists has evolved since the dawn of DP/AI
- 19:55 Pharma perspective on how DP/AI will drive the future of precision medicine
- 25:00 Increasing DP adoption in the pharma industry
- 28:40 Digital pathology bringing better patient care around the world
Episode 8 - Esther Abels, MSc | Visiopharm; DPA President-Elect (posted April 2021)
Esther Abels, co-chair of the DPA Regulatory & Standards Task Force, has worked on the regulatory approval of digital pathology systems since the beginning. She joins Beyond The Scope to discuss her current role advancing the regulatory science of digital pathology and provides an update on the initiatives of the DPA Regulatory and Standards Task Force. Esther also discusses the excitement surrounding digital pathology for precision medicine.
- 2:21 Introduction
- 6:25 Early applications of digital pathology to the pharma industry
- 8:00 Process of validating and achieving FDA approval of the first slide scanners
- 10:00 How collaboration and teamwork help achieve regulatory approval
- 17:48 Current initiatives of the DPA Regulatory and Standars Task Force
- 21:40 510(k) exemption of digital pathology devices
- 25:00 Real world data initiative and is remote sign out permanent?
- 31:08 Using digital pathology for precision medicine
Episode 7 - Dr. Talat Zehra, MBBS, FCPS | Jinnah Sindh Medical University, Karachi, Pakistan (posted March 2021)
Talat Zehra is a pathologist at Jinnah Sindh University in Karachi, Pakistan. Dr. Zehra joins Beyond The Scope to share how the scarcity of pathologists in Pakistan and many other regions of the world affect patient care. Dr. Zehra also discusses the advantages and challenges of bringing digital pathology to developing countries.
- 1:00 Introduction
- 3:30 Dr. Zehra's research with WSI in Pakistan
- 6:15 Pathology services in Pakistan and other developing countries
- 13:15 Pathology in rural areas of the world
- 14:33 Benefits of digital pathology in developing countries
- 17:42 Challenges of digital pathology adoption in developing countries
- 19:05 Ideas for vendors and other pathologists to help increase adoption in developing countries
Please visit other resources mentioned in this podcast:
Episode 6 - Liron Pantanowitz, MD | University of Michigan; DPA Treasurer (posted March 2021)
Liron Pantanowitz is an early adopter and major driving force behind global digital pathology adoption. He currently serves as a Professor in the Department of Pathology at the University of Michigan and has authored hundreds of papers related to digital pathology. Dr. Pantanowitz joins David and Giovanni to discuss the past, present, and future of digital pathology. This podcast is a must-listen for all levels of digital pathology adopters.
- 5:45 Introduction and background leading to a career focused on digital pathology
- 8:38 Milestones of digital pathology adoption
- 12:10 Digital pathology applications and the business case
- 15:46 The effect of COVID-19 on digital pathology adoption
- 23:23 Global digital pathology adoption
- 29:00 Training the next generation of digital pathologists
- 41:04 What's next for digital pathology
Episode 5 - Monica Santamaria-Fries, MD | Proscia (posted March 2021)
Monica Santamaria-Fries is the Digital Transformation Officer at Proscia, a role where she uses her extensive experience as a pathologist to bridge the gap in communicating novel digital pathology technology to the pathology community. Dr. Santamaria-Fries joins the show to discuss her role in digital pathology innovation, the annual digital pathology report generated by Proscia, and why the time is now for digital pathology adoption.
- 3:34 Introduction and background
- 8:50 Pathologists bridging the gap when communicating new technologies to other pathologists
- 12:04 New innovations in computation pathology and improved pathology workflow
- 19:43 Moments that trigger pathologists to want to go digital
- 27:57 Highlights of the annual digital pathology report
- 29:11 Why now is the time to go digital and how to remove roadblocks
Episode 4 - Joe Lennerz, MD, PhD | Massachusetts General Hospital (posted February 2021)
Joe Lennerz is the Director of the Center of Integrated Diagnostics at Massachusetts General Hospital and a founding member of The Alliance for Digital Pathology. Dr. Lennerz sits down with Giovanni and David to discuss innovating in the digital pathology space, regulatory science related to digital pathology, and the initiatives of The Alliance. For more resources on Dr. Lennerz's work and how to get involved with The Alliance for Digital Pathology, please click here.
- 4:38 Introduction and background
- 6:35 Implementing innovative diagnostics in clinical practice
- 20:23 Formation of The Alliance for Digital Pathology and applying regulatory science to digital pathology innovation
- 27:29 Current goals and initiatives directed by The Alliance
- 32:25 Getting involved with The Alliance and how to connect with key stakeholders in digital pathology innovation
Episode 3 - Michael Rivers | Roche; DPA Immediate Past President (posted January 2021)
Michael Rivers just completed his term as DPA president and joins David and Giovanni to discuss the numerous initiatives in which the DPA was involved while navigating COVID-19. Plus, he gives an industry perspective on the future of the digital pathology industry.
Episode 2 - Anil Parwani, MD, PhD, MBA | Ohio State University; DPA President (posted December 2020)
Dr. Anil Parwani (OSUWMC) joins the show to share why he chose to pursue a career focusing on digital pathology and gives advice to departments looking to start a digital pathology program.
Episode 1 - An Introduction
Dr. Giovanni Lujan and Dr. David Tulman preview the concept of the podcast, discuss their backgrounds in digital pathology, and project the future of pathology.